BNY Mellon (BNY)

BNY Mellon's stock sits at $152.69, 7.93% below its 52-week high of $165.84 and 78% of the way up its 52-week range, after a 37.25% gain over the past year. The shares have been firm rather than frothy: the price is 2.01% above the 50-day average and 8.63% above the 200-day average, and the one-month return is 6.89%. The stock has also had a steady earnings record, beating EPS estimates in all eight of the most recent reports, which is the backdrop for a valuation that is close to the sector median. Investors are weighing whether the earnings momentum and analyst support can carry the shares back toward the high.

BNY has beaten EPS estimates in all eight of the reports the record covers. The most recent one, dated October 15, 2026, showed adjusted EPS of $2.37 against an estimate of $2.26, a beat of 4.87%, and the stock rose 3.23% in the first session afterward. The July 15, 2026 report beat the estimate by 10.81%, with the shares up 5.08% the next session, but the April 16, 2026 report produced the largest beat of the last four at 16.58%. Not every beat was rewarded: two of the eight were followed by a lower price in the first session, so a clean beat does not guarantee a rally.

The trailing P/E is 16.91, broadly in line with the sector median of 16.5. On sales the stock is pricier, with a price-to-sales ratio of 4.63 against a sector median of 3.8, 21.8% above. Profitability helps justify that premium: the net profit margin is 28.6%, the operating margin is 39.07%, and return on equity is 14.87%, above the sector median of 13.8%.

Over the last 18 months, insiders sold $22.5M of stock in recent filings and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market buying would be. Still, the absence of insider buying is one fact a shareholder may want to weigh alongside the strong earnings record.

The base case is that BNY keeps trading above its 50-day and 200-day moving averages ($149.68 and $140.56) as long as earnings keep meeting or beating estimates. Analysts expect EPS to rise 25.7% this year to $9.43 and a further 10.7% next year to $10.44, and revenue is expected to grow 12.0% this year. Analysts' median 12-month target is $165.00, close to the 52-week high, with a range of $135.00 to $182.00. A move back toward the high would need the next earnings reports to keep beating, since the stock's typical daily move is 1.36%. A break below the 50-day average would weaken the trend case, and a fall toward the 200-day average would test the thesis that the uptrend is intact.

Nearest support is the 50-day simple moving average at $149.68, followed closely by the 20-day exponential moving average at $148.51. The 200-day simple moving average at $140.56 is the next support below the price, and the 52-week low of $105.42 is the deepest level below the price. Resistance sits at the 52-week high of $165.84, the only level above the price.